Loading...

KNSA KINIKSA PHARMACEUTICALS INTERNATIONAL PLC Investments/Divestments 8-K Filing

KNKS

KNS

KINIKSA PHARMACEUTICALS INTERNATIONAL PLC

(KNSA)

2024 8-K

Financial Results Announced

Investor Presentation Update

Financial Statements

Product Expansion

Management Changes

Product Expansion

License Termination

Financial Results

Q3 Earnings Report

Board Appointment

Earnings Reports

Agreement with Samsung Biol...

Redomiciliation

Annual Meeting and Special ...

Earnings Reports

Redomiciliation Proposal

Earnings Reports

Financial Results

Earnings Reports

Earnings Releases

Annual Meeting of Shareholders

Earnings Reports

Regulation FD Disclosure

Earnings Reports

Financial Results Announcement

External Links:

Kiniksa Pharmaceuticals, Ltd. entered into a Master Services Agreement and Product Specific Agreement with Samsung Biologics Co., Ltd. for the supply of their drug substance ARCALYST.

AI Assistant

KINIKSA PHARMACEUTICALS INTERNATIONAL PLC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.